Compare Unichem Lab with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs SUN PHARMA - Comparison Results

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB SUN PHARMA UNICHEM LAB/
SUN PHARMA
 
P/E (TTM) x -85.5 20.5 - View Chart
P/BV x 0.5 2.2 21.5% View Chart
Dividend Yield % 2.9 0.7 402.6%  

Financials

 UNICHEM LAB   SUN PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
SUN PHARMA
Mar-19
UNICHEM LAB/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs292679 43.0%   
Low Rs182375 48.5%   
Sales per share (Unadj.) Rs167.7121.1 138.4%  
Earnings per share (Unadj.) Rs-3.613.4 -27.1%  
Cash flow per share (Unadj.) Rs5.920.7 28.7%  
Dividends per share (Unadj.) Rs4.002.75 145.5%  
Dividend yield (eoy) %1.70.5 323.5%  
Book value per share (Unadj.) Rs372.3172.6 215.7%  
Shares outstanding (eoy) m70.382,399.26 2.9%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.44.4 32.5%   
Avg P/E ratio x-65.339.4 -165.7%  
P/CF ratio (eoy) x39.925.5 156.5%  
Price / Book Value ratio x0.63.1 20.8%  
Dividend payout %-110.220.6 -535.9%   
Avg Mkt Cap Rs m16,6801,264,650 1.3%   
No. of employees `0002.617.5 14.9%   
Total wages/salary Rs m2,39359,671 4.0%   
Avg. sales/employee Rs Th4,535.216,608.1 27.3%   
Avg. wages/employee Rs Th919.83,409.6 27.0%   
Avg. net profit/employee Rs Th-98.21,833.8 -5.4%   
INCOME DATA
Net Sales Rs m11,801290,659 4.1%  
Other income Rs m98410,255 9.6%   
Total revenues Rs m12,785300,914 4.2%   
Gross profit Rs m-83563,076 -1.3%  
Depreciation Rs m67417,533 3.8%   
Interest Rs m755,553 1.4%   
Profit before tax Rs m-60050,246 -1.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m0-12,144 0.0%   
Tax Rs m-3436,009 -5.7%   
Profit after tax Rs m-25632,093 -0.8%  
Gross profit margin %-7.121.7 -32.6%  
Effective tax rate %57.312.0 478.9%   
Net profit margin %-2.211.0 -19.6%  
BALANCE SHEET DATA
Current assets Rs m20,384310,692 6.6%   
Current liabilities Rs m5,029173,396 2.9%   
Net working cap to sales %130.147.2 275.5%  
Current ratio x4.11.8 226.2%  
Inventory Days Days10599 105.8%  
Debtors Days Days135112 120.9%  
Net fixed assets Rs m9,023232,477 3.9%   
Share capital Rs m1412,399 5.9%   
"Free" reserves Rs m26,058411,691 6.3%   
Net worth Rs m26,199414,091 6.3%   
Long term debt Rs m015,226 0.0%   
Total assets Rs m31,496646,938 4.9%  
Interest coverage x-7.010.0 -69.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.40.4 83.4%   
Return on assets %-0.65.8 -9.8%  
Return on equity %-1.07.8 -12.6%  
Return on capital %-2.010.2 -19.7%  
Exports to sales %69.40-   
Imports to sales %00-   
Exports (fob) Rs m8,188NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m8,18866,025 12.4%   
Fx outflow Rs m59638,610 1.5%   
Net fx Rs m7,59227,415 27.7%   
CASH FLOW
From Operations Rs m-3,27821,965 -14.9%  
From Investments Rs m-2,860-6,813 42.0%  
From Financial Activity Rs m-24-27,305 0.1%  
Net Cashflow Rs m-4,690-8,442 55.6%  

Share Holding

Indian Promoters % 50.1 63.7 78.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 5.1 294.3%  
FIIs % 3.0 23.0 13.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 8.3 381.9%  
Shareholders   20,176 133,026 15.2%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   VENUS REMEDIES  PROCTER & GAMBLE HEALTH  SANOFI INDIA  TTK HEALTHCARE  ORCHID PHARMA LTD  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Falls 250 Points; Sun Pharma & Maruti Suzuki Top Losers(12:30 pm)

Share markets in India are presently trading on a negative note, tracking a massive sell-off overnight on the Wall Street amid concerns over the Covid-19 spreading beyond China.

Related Views on News

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, SUN PHARMA has posted a net profit of Rs 10 bn (down 29.8% YoY). Sales on the other hand came in at Rs 82 bn (up 5.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

More Views on News

Most Popular

The Next Few Days Are Crucial for Smallcap Investors - And 3 Must-Buy Stocks(Profit Hunter)

Feb 19, 2020

While I have been writing about the rebound in smallcaps for quite some time now... I have shied from the question - When exactly is the smallcap rebound happening. Well, the answer is now.

Here's Why I Recommended 15 Stocks in One Day Flat(Views On News)

Feb 14, 2020

This proven strategy can give big returns in quick time.

The Top 8 Trading Mistakes You Should Avoid(Fast Profits Daily)

Feb 18, 2020

Avoid these mistakes and your trading will turn much more profitable.

Corona Virus Could Trigger a Rally in this Stock(Profit Hunter)

Feb 20, 2020

A company which benefits from crude oil and coronavirus - if you would like to know more about it read this.

These Rebirth of India Stocks Are Raring to Compete with Tesla(The 5 Minute Wrapup)

Feb 17, 2020

There are Indian stocks which can soar like Tesla in the long-run.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Feb 26, 2020 03:17 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS